Multimodal artificial intelligence prediction of abiraterone efficacy in two STAMPEDE phase III trials of nonmetastatic very high-risk prostate cancer☆
Publication date: October 2026 Source: Annals of Oncology, Volume 37, Issue 10 Author(s): C.T.A. Parker, H-C. Huang, E. Grist, L. Mendes, R. Yamashita, D. Croucher, A. Sachdeva, L. Murphy, V.Y.T. Liu, S. Santos Vidal, T. Todorovic, S. Lall, M. Goncalves, S. Thakali, A. Wingate, L. Zakka, D. Wetterskog, K. Nowakowska, C.L. Amos, D.M. Berney
Multimodal artificial intelligence prediction of abiraterone efficacy in two STAMPEDE phase III trials of nonmetastatic very high-risk prostate cancer☆. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426009142?dgcid=rss_sd_all
Multimodal artificial intelligence prediction of abiraterone efficacy in two STAMPEDE phase III trials of nonmetastatic very high-risk prostate cancer☆. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426009142?dgcid=rss_sd_all
“Multimodal artificial intelligence prediction of abiraterone efficacy in two STAMPEDE phase III trials of nonmetastatic very high-risk prostate cancer☆.” Annals of Oncology.
@article{article93201,
title = {Multimodal artificial intelligence prediction of abiraterone efficacy in two STAMPEDE phase III trials of nonmetastatic very high-risk prostate cancer☆},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426009142?dgcid=rss_sd_all}
}
ABSTRACT Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study...
Abstract Background and Objectives Perioperative blood transfusion in hip arthroplasty is associated with increased morbidity, prolonged hospitalization, and higher costs. This study aimed to identify independent risk factors and...